Head-to-head · Value Score
CoreAge Rx vs Primary Clinic (Direct GLP)
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Primary Clinic (Direct GLP) a 70. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-namePrimary Clinic (Direct GLP)
#221 · Grade C · Watch List
Est. first month
From $85/mo (0.25-0.75 mg band, membership required, compounded)
Save ~87% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 70 — an est. $99/mo first month, with no teaser step-up baked in. Primary Clinic (Direct GLP) isn't out of it: Shoppers in one of the 10 covered states who want unlimited primary care bundled with their GLP-1 and will pay a membership to get wholesale drug pricing.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Primary Clinic (Direct GLP) |
|---|---|---|
| Value Score | 93 (A+) | 70 (C) |
| Est. first month | $99/mo | From $85/mo (0.25-0.75 mg band, membership required, compounded) |
| Save vs brand-name | ~89% | ~87% |
| Semaglutide | $99/mo | From $85/mo (0.25-0.75 mg band, membership required, compounded) |
| Tirzepatide | $149/mo | From $133/mo (1.25-2.5 mg band, membership required, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 10 states (WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA) |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Primary Clinic (Direct GLP)
A 10-state direct-primary-care clinic selling GLP-1s at wholesale to its own members — cheap per milligram, but only on top of an $89/mo membership.
Why it's a deal
- Medication is billed at the clinic's wholesale cost with no markup, and the whole dose ladder is published rather than hidden behind intake
- The $89 membership also covers unlimited primary care, routine labs and prescription management, not GLP-1 care alone
The fine print
- The medication price sits on top of an $89/mo membership which the site's own FAQ states does NOT include the drug — about $174/mo all-in for semaglutide and $222/mo for tirzepatide
- Prices are published as dose BANDS and step up steeply as you titrate: semaglutide runs $85, $108, $145 then $183, so the entry figure is not what a maintenance dose costs
- The entire catalog renders only in JavaScript — the served HTML body is empty, so nothing is readable without running the site's bundle
- Only 10 states, small clinic, and not LegitScript-certified
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Primary Clinic (Direct GLP).
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.